Adverse drug reactions at a university hospital in Brazil

Detalhes bibliográficos
Autor(a) principal: Toledo, L. A. Kister de
Data de Publicação: 2010
Outros Autores: Noblat, L., Noblat, A.C.B., Oliveira, M.G., Santos, P.M.
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UFBA
Texto Completo: http://repositorio.ufba.br/ri/handle/ri/22710
Resumo: Abstract The aim of this study is to characterize the patients and the ADR notified to a Pharmacovigilance Center at a university hospital in Brazil. The ADR rate in hospitalized patients is 10% to 20% and the frequency of hospitalization due to ADR is 0,5% to 6,5%. The ADRs contribute to the increase of length in hospitalization and costs. Patient’s exposures have an increase in the rate of mortality, although about 60% to 80% could be prevented. A descriptive study carried at a university hospital in Northeast of Brazil, where all the spontaneous notifications were analyzed during two years. For the process of notification of ADR suspicions, WHO definition was used. After receiving the notification, ADR suspicions were analyzed and the causality assessment was done by CFV staff members, using three different algorithms, and classified according to severity and type. Seventy eight ADR suspicions were spontaneously notified. The female gender represented 55% of cases. Black and mulatto races represented 70%. The most frequent organ and system affected was the skin. Medicines most frequently involved in ADR were anti-infectious agents followed by anti-parasitic agents. The causality assessment shows that the frequency of certain and probable ADRs were around 55%. ADRs severity was moderate in 41%, although more than 60% of all ADRs could be prevented. ADRs are a major problem and measures must be adopted to minimize them.
id UFBA-2_d72a06c5a91c9fe1ff946d8ee64b6b90
oai_identifier_str oai:repositorio.ufba.br:ri/22710
network_acronym_str UFBA-2
network_name_str Repositório Institucional da UFBA
repository_id_str 1932
spelling Toledo, L. A. Kister deNoblat, L.Noblat, A.C.B.Oliveira, M.G.Santos, P.M.Toledo, L. A. Kister deNoblat, L.Noblat, A.C.B.Oliveira, M.G.Santos, P.M.2017-06-01T19:33:56Z2017-06-01T19:33:56Z2010R. Ci. méd. biol., v. 9, Supl.1, p. 40-45, 2010.1677-5090http://repositorio.ufba.br/ri/handle/ri/22710v.9, n.1Abstract The aim of this study is to characterize the patients and the ADR notified to a Pharmacovigilance Center at a university hospital in Brazil. The ADR rate in hospitalized patients is 10% to 20% and the frequency of hospitalization due to ADR is 0,5% to 6,5%. The ADRs contribute to the increase of length in hospitalization and costs. Patient’s exposures have an increase in the rate of mortality, although about 60% to 80% could be prevented. A descriptive study carried at a university hospital in Northeast of Brazil, where all the spontaneous notifications were analyzed during two years. For the process of notification of ADR suspicions, WHO definition was used. After receiving the notification, ADR suspicions were analyzed and the causality assessment was done by CFV staff members, using three different algorithms, and classified according to severity and type. Seventy eight ADR suspicions were spontaneously notified. The female gender represented 55% of cases. Black and mulatto races represented 70%. The most frequent organ and system affected was the skin. Medicines most frequently involved in ADR were anti-infectious agents followed by anti-parasitic agents. The causality assessment shows that the frequency of certain and probable ADRs were around 55%. ADRs severity was moderate in 41%, although more than 60% of all ADRs could be prevented. ADRs are a major problem and measures must be adopted to minimize them.Submitted by ROBERTO PAULO CORREIA DE ARAÚJO (ppgorgsistem@ufba.br) on 2017-06-01T19:33:56Z No. of bitstreams: 1 8_v.9_1.pdf: 111976 bytes, checksum: 1f1f97e4d640493b3d52bdf21f06581b (MD5)Made available in DSpace on 2017-06-01T19:33:56Z (GMT). No. of bitstreams: 1 8_v.9_1.pdf: 111976 bytes, checksum: 1f1f97e4d640493b3d52bdf21f06581b (MD5) Previous issue date: 2010-01SalvadorInstituto de Ciências da Saúde/ Universidade Federal da BahiaBrasilhttp://www.portalseer.ufba.br/index.php/cmbio/article/view/4639/3473reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAFarmacovigilância/Reações adversasMedicamentos /Efeitos dversosAdverse drug reactions at a university hospital in BrazilRevista de Ciências Médicas e Biológicasinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessporORIGINAL8_v.9_1.pdf8_v.9_1.pdfapplication/pdf111976https://repositorio.ufba.br/bitstream/ri/22710/1/8_v.9_1.pdf1f1f97e4d640493b3d52bdf21f06581bMD51LICENSElicense.txtlicense.txttext/plain1383https://repositorio.ufba.br/bitstream/ri/22710/2/license.txt05eca2f01d0b3307819d0369dab18a34MD52TEXT8_v.9_1.pdf.txt8_v.9_1.pdf.txtExtracted texttext/plain25265https://repositorio.ufba.br/bitstream/ri/22710/3/8_v.9_1.pdf.txt99a5341350961932681a45fdc8fcc024MD53ri/227102022-11-03 14:32:40.54oai:repositorio.ufba.br:ri/22710VGVybW8gZGUgTGljZW7Dp2EsIG7Do28gZXhjbHVzaXZvLCBwYXJhIG8gZGVww7NzaXRvIG5vIFJlcG9zaXTDs3JpbyBJbnN0aXR1Y2lvbmFsIGRhIFVGQkEuCgogUGVsbyBwcm9jZXNzbyBkZSBzdWJtaXNzw6NvIGRlIGRvY3VtZW50b3MsIG8gYXV0b3Igb3Ugc2V1IHJlcHJlc2VudGFudGUgbGVnYWwsIGFvIGFjZWl0YXIgCmVzc2UgdGVybW8gZGUgbGljZW7Dp2EsIGNvbmNlZGUgYW8gUmVwb3NpdMOzcmlvIEluc3RpdHVjaW9uYWwgZGEgVW5pdmVyc2lkYWRlIEZlZGVyYWwgZGEgQmFoaWEgCm8gZGlyZWl0byBkZSBtYW50ZXIgdW1hIGPDs3BpYSBlbSBzZXUgcmVwb3NpdMOzcmlvIGNvbSBhIGZpbmFsaWRhZGUsIHByaW1laXJhLCBkZSBwcmVzZXJ2YcOnw6NvLiAKRXNzZXMgdGVybW9zLCBuw6NvIGV4Y2x1c2l2b3MsIG1hbnTDqm0gb3MgZGlyZWl0b3MgZGUgYXV0b3IvY29weXJpZ2h0LCBtYXMgZW50ZW5kZSBvIGRvY3VtZW50byAKY29tbyBwYXJ0ZSBkbyBhY2Vydm8gaW50ZWxlY3R1YWwgZGVzc2EgVW5pdmVyc2lkYWRlLgoKIFBhcmEgb3MgZG9jdW1lbnRvcyBwdWJsaWNhZG9zIGNvbSByZXBhc3NlIGRlIGRpcmVpdG9zIGRlIGRpc3RyaWJ1acOnw6NvLCBlc3NlIHRlcm1vIGRlIGxpY2Vuw6dhIAplbnRlbmRlIHF1ZToKCiBNYW50ZW5kbyBvcyBkaXJlaXRvcyBhdXRvcmFpcywgcmVwYXNzYWRvcyBhIHRlcmNlaXJvcywgZW0gY2FzbyBkZSBwdWJsaWNhw6fDtWVzLCBvIHJlcG9zaXTDs3Jpbwpwb2RlIHJlc3RyaW5naXIgbyBhY2Vzc28gYW8gdGV4dG8gaW50ZWdyYWwsIG1hcyBsaWJlcmEgYXMgaW5mb3JtYcOnw7VlcyBzb2JyZSBvIGRvY3VtZW50bwooTWV0YWRhZG9zIGVzY3JpdGl2b3MpLgoKIERlc3RhIGZvcm1hLCBhdGVuZGVuZG8gYW9zIGFuc2Vpb3MgZGVzc2EgdW5pdmVyc2lkYWRlIGVtIG1hbnRlciBzdWEgcHJvZHXDp8OjbyBjaWVudMOtZmljYSBjb20gCmFzIHJlc3RyacOnw7VlcyBpbXBvc3RhcyBwZWxvcyBlZGl0b3JlcyBkZSBwZXJpw7NkaWNvcy4KCiBQYXJhIGFzIHB1YmxpY2HDp8O1ZXMgc2VtIGluaWNpYXRpdmFzIHF1ZSBzZWd1ZW0gYSBwb2zDrXRpY2EgZGUgQWNlc3NvIEFiZXJ0bywgb3MgZGVww7NzaXRvcyAKY29tcHVsc8OzcmlvcyBuZXNzZSByZXBvc2l0w7NyaW8gbWFudMOqbSBvcyBkaXJlaXRvcyBhdXRvcmFpcywgbWFzIG1hbnTDqm0gYWNlc3NvIGlycmVzdHJpdG8gCmFvIG1ldGFkYWRvcyBlIHRleHRvIGNvbXBsZXRvLiBBc3NpbSwgYSBhY2VpdGHDp8OjbyBkZXNzZSB0ZXJtbyBuw6NvIG5lY2Vzc2l0YSBkZSBjb25zZW50aW1lbnRvCiBwb3IgcGFydGUgZGUgYXV0b3Jlcy9kZXRlbnRvcmVzIGRvcyBkaXJlaXRvcywgcG9yIGVzdGFyZW0gZW0gaW5pY2lhdGl2YXMgZGUgYWNlc3NvIGFiZXJ0by4KRepositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-11-03T17:32:40Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false
dc.title.pt_BR.fl_str_mv Adverse drug reactions at a university hospital in Brazil
dc.title.alternative.pt_BR.fl_str_mv Revista de Ciências Médicas e Biológicas
title Adverse drug reactions at a university hospital in Brazil
spellingShingle Adverse drug reactions at a university hospital in Brazil
Toledo, L. A. Kister de
Farmacovigilância/Reações adversas
Medicamentos /Efeitos dversos
title_short Adverse drug reactions at a university hospital in Brazil
title_full Adverse drug reactions at a university hospital in Brazil
title_fullStr Adverse drug reactions at a university hospital in Brazil
title_full_unstemmed Adverse drug reactions at a university hospital in Brazil
title_sort Adverse drug reactions at a university hospital in Brazil
author Toledo, L. A. Kister de
author_facet Toledo, L. A. Kister de
Noblat, L.
Noblat, A.C.B.
Oliveira, M.G.
Santos, P.M.
author_role author
author2 Noblat, L.
Noblat, A.C.B.
Oliveira, M.G.
Santos, P.M.
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Toledo, L. A. Kister de
Noblat, L.
Noblat, A.C.B.
Oliveira, M.G.
Santos, P.M.
Toledo, L. A. Kister de
Noblat, L.
Noblat, A.C.B.
Oliveira, M.G.
Santos, P.M.
dc.subject.por.fl_str_mv Farmacovigilância/Reações adversas
Medicamentos /Efeitos dversos
topic Farmacovigilância/Reações adversas
Medicamentos /Efeitos dversos
description Abstract The aim of this study is to characterize the patients and the ADR notified to a Pharmacovigilance Center at a university hospital in Brazil. The ADR rate in hospitalized patients is 10% to 20% and the frequency of hospitalization due to ADR is 0,5% to 6,5%. The ADRs contribute to the increase of length in hospitalization and costs. Patient’s exposures have an increase in the rate of mortality, although about 60% to 80% could be prevented. A descriptive study carried at a university hospital in Northeast of Brazil, where all the spontaneous notifications were analyzed during two years. For the process of notification of ADR suspicions, WHO definition was used. After receiving the notification, ADR suspicions were analyzed and the causality assessment was done by CFV staff members, using three different algorithms, and classified according to severity and type. Seventy eight ADR suspicions were spontaneously notified. The female gender represented 55% of cases. Black and mulatto races represented 70%. The most frequent organ and system affected was the skin. Medicines most frequently involved in ADR were anti-infectious agents followed by anti-parasitic agents. The causality assessment shows that the frequency of certain and probable ADRs were around 55%. ADRs severity was moderate in 41%, although more than 60% of all ADRs could be prevented. ADRs are a major problem and measures must be adopted to minimize them.
publishDate 2010
dc.date.issued.fl_str_mv 2010
dc.date.accessioned.fl_str_mv 2017-06-01T19:33:56Z
dc.date.available.fl_str_mv 2017-06-01T19:33:56Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv R. Ci. méd. biol., v. 9, Supl.1, p. 40-45, 2010.
dc.identifier.uri.fl_str_mv http://repositorio.ufba.br/ri/handle/ri/22710
dc.identifier.issn.none.fl_str_mv 1677-5090
dc.identifier.number.pt_BR.fl_str_mv v.9, n.1
identifier_str_mv R. Ci. méd. biol., v. 9, Supl.1, p. 40-45, 2010.
1677-5090
v.9, n.1
url http://repositorio.ufba.br/ri/handle/ri/22710
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Instituto de Ciências da Saúde/ Universidade Federal da Bahia
dc.publisher.country.fl_str_mv Brasil
publisher.none.fl_str_mv Instituto de Ciências da Saúde/ Universidade Federal da Bahia
dc.source.pt_BR.fl_str_mv http://www.portalseer.ufba.br/index.php/cmbio/article/view/4639/3473
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFBA
instname:Universidade Federal da Bahia (UFBA)
instacron:UFBA
instname_str Universidade Federal da Bahia (UFBA)
instacron_str UFBA
institution UFBA
reponame_str Repositório Institucional da UFBA
collection Repositório Institucional da UFBA
bitstream.url.fl_str_mv https://repositorio.ufba.br/bitstream/ri/22710/1/8_v.9_1.pdf
https://repositorio.ufba.br/bitstream/ri/22710/2/license.txt
https://repositorio.ufba.br/bitstream/ri/22710/3/8_v.9_1.pdf.txt
bitstream.checksum.fl_str_mv 1f1f97e4d640493b3d52bdf21f06581b
05eca2f01d0b3307819d0369dab18a34
99a5341350961932681a45fdc8fcc024
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)
repository.mail.fl_str_mv
_version_ 1808459509692104704